Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Symmetry Surgical's Total Stockholders Equity for the quarter that ended in Sep. 2014 was €216.7 Mil. Symmetry Surgical's Total Assets for the quarter that ended in Sep. 2014 was €396.8 Mil.
Therefore, Symmetry Surgical's Equity to Asset Ratio for the quarter that ended in Sep. 2014 was 0.55.
The historical rank and industry rank for Symmetry Surgical's Equity-to-Asset or its related term are showing as below:
FRA:RZV'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.37 Med: 0.59 Max: 0.77
Current: 0.55
During the past 13 years, the highest Equity to Asset Ratio of Symmetry Surgical was 0.77. The lowest was 0.37. And the median was 0.59.
FRA:RZV's Equity-to-Asset is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 0.64
vs FRA:RZV: 0.55
Symmetry Surgical Equity-to-Asset Historical Data
The historical data trend for Symmetry Surgical's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Symmetry Surgical's Equity-to-Asset
For the Medical Devices subindustry, Symmetry Surgical's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Symmetry Surgical's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Symmetry Surgical's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Symmetry Surgical's Equity-to-Asset falls into.
Symmetry Surgical Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Symmetry Surgical's Equity to Asset Ratio for the fiscal year that ended in Dec. 2013 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Symmetry Surgical Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of Symmetry Surgical's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Symmetry Medical, Inc., is a Delaware corporation incorporated on July 25, 1996. It is a source of medical device products. The Company provides medical device solutions, including surgical instruments, orthopedic implants, and sterilization cases and trays. The Company designs, develops and offers worldwide production and supply chain capabilities for these products to customers in the orthopedic industry and other medical device markets. It also manufactures specialized non-healthcare products, mainly in the aerospace industry. It operates in two reportable segments namely Original Equipment Manufacturer (OEM) Solutions and Symmetry Surgical. Its main products produced in the OEM Solutions segment include: implants, including forged, cast and machined products for the global orthopedic device market; instruments used in the placement and removal of orthopedic implants and in other surgical procedures; cases, including plastic, metal and hybrid cases used to organize, secure and transport medical devices for orthopedic, endoscopy, dental and other surgical procedures; and other specialized products for the aerospace market. Symmetry Surgical is its new business segment. It arose from the integration of the Codman and Olsen Medical lines of surgical instruments with its Company's already existing hospital direct business, Specialty Surgical Instrumentation (SSI). Symmetry Surgical, which is headquartered in Nashville, Tennessee offers reusable stainless steel and titanium surgical hand-held instruments and retractor systems, sterile disposable surgical products, and sterilization containers. These products are used in the surgical specialties of spine, general/obstetrics/gynecology, microsurgery/neurosurgery, orthopedics, and laparoscopy, cardiovascular, thoracic and general surgery in the hospital setting as well as surgery centers and in select physician offices. The Company's OEM Solutions segment has manufacturing facilities in the U.S., United Kingdom, France, Ireland and Malaysia. The Company's subject to federal, state and local environmental laws and regulations governing the emission, discharge, use, storage and disposal of hazardous materials and the remediation of contamination associated with the release of these materials at our facilities and at off-site disposal locations.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:RZV has been successfully added to your 